A 38-year-old Indian woman with a 3-year history of Meniere disease (left ear) presents with her third severe vertigo attack this month. Previous attacks lasted 4–6 hours with associated nausea and vomiting. Audiometry shows progressive low-to-mid frequency sensorineural hearing loss on the left, with incomplete recovery after the last two episodes. She has been on a low-sodium diet and hydrochlorothiazide 25 mg daily for 18 months with diminishing benefit. She is now unable to work due to unpredictable attacks. What is the most appropriate next step in management?

Explanation

## Management of Refractory Meniere Disease ### Clinical Context: Treatment Escalation **Key Point:** This patient has **refractory (intractable) Meniere disease** — defined as inadequate symptom control despite ≥3 months of medical therapy (salt restriction + diuretics). She requires escalation beyond conservative management. ### Treatment Algorithm for Meniere Disease ```mermaid flowchart TD A[Meniere Disease Diagnosed]:::outcome --> B[First-Line: Salt Restriction + Diuretics]:::action B --> C{Response at 3 Months?}:::decision C -->|Good| D[Continue Medical Management]:::action C -->|Partial/Poor| E[Refractory Meniere]:::outcome E --> F{Hearing Preservation Priority?}:::decision F -->|Yes| G[Intratympanic Gentamicin or Steroids]:::action F -->|No/Severe| H[Labyrinthectomy or Vestibular Nerve Section]:::action G --> I[Ablate Vestibular Function]:::action H --> J[Definitive Surgical Management]:::action ``` ### Why Intratympanic Gentamicin Is Optimal Here | Criterion | Rationale | |-----------|----------| | **Refractory status** | Patient has failed 18 months of medical therapy with increasing attack frequency | | **Hearing preservation** | Gentamicin preferentially ablates vestibular (not cochlear) function; hearing loss may stabilize | | **Invasiveness** | Less invasive than labyrinthectomy; can be repeated if needed | | **Efficacy** | ~70–90% control of vertigo attacks in refractory cases | | **Mechanism** | Ototoxic aminoglycoside destroys vestibular hair cells → reduces vertigo attacks | **High-Yield:** Intratympanic gentamicin is the **standard second-line agent** for refractory Meniere disease when hearing preservation is a priority. ### Intratympanic Gentamicin Protocol 1. **Dose & Route**: 26.7 mg/mL gentamicin (0.4–0.5 mL) injected into middle ear via tympanic membrane 2. **Frequency**: Single injection or monthly injections × 3–4 doses 3. **Timing**: Patient remains supine 30 minutes to allow diffusion into round window 4. **Monitoring**: Audiometry before and after; caloric testing to assess vestibular ablation 5. **Success**: ~80% achieve significant vertigo control; hearing may stabilize or worsen slightly **Clinical Pearl:** Gentamicin is **vestibulotoxic > cochleotoxic**, making it safer for hearing than streptomycin. However, some hearing loss risk remains (~20–30% experience further decline). ### Why Other Options Are Suboptimal #### Option A: Increase Diuretic Dose - Patient has already failed standard-dose medical therapy for 18 months - Increasing hydrochlorothiazide alone is unlikely to control refractory disease - Does not address the underlying endolymphatic hydrops adequately - Delays definitive intervention for a functionally disabled patient #### Option C: Oral Corticosteroids - Prednisolone is **not standard first-line** for Meniere disease - May have a role in **autoimmune inner ear disease** (bilateral, progressive), not typical unilateral Meniere - No robust evidence for 2-week course in refractory vertigo - Delays more effective intervention #### Option D: Endolymphatic Sac Decompression - Surgical option reserved for **failed medical + intratympanic therapy** - More invasive than intratympanic injection - Success rates variable (50–70%); less predictable than gentamicin - Appropriate if gentamicin fails or patient prefers definitive surgery - **Not first-line** for refractory disease ### Decision Tree: When to Use Each Intervention | Stage | Intervention | Indication | |-------|--------------|------------| | **First-line** | Salt restriction + diuretics | All newly diagnosed Meniere | | **Second-line** | Intratympanic gentamicin/steroids | Refractory to medical therapy; hearing preservation desired | | **Third-line** | Labyrinthectomy or vestibular nerve section | Failed intratympanic therapy; hearing already lost or not a priority | **Mnemonic:** **GENTS** = **G**entamicin (intratympanic), **E**scalation from medical therapy, **N**ew vestibular ablation, **T**reatment of refractory disease, **S**econd-line agent